Reversal of hyperglycemia by protein transduction of NeuroD in vivo

Acta Pharmacologica Sinica

Volumn 28, Issue 8, 2007, Pages 1181-1188

  Huang, Yin ^a   Chen, Jing ^a   Li, Ge ^a   Cheng, Tian Yue ^a   Jiang, Ming Hong ^a   Zhang, Shu Yu ^a   Lu, Jun ^a   Yan, Shi ^a   Fan, Wei Wei ^a   Lu, Da Ru ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Insulin; Intestines; Neurogenic differentiation 1; Type 1 diabetes mellitus

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FROZEN SECTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; GENE THERAPY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; INTESTINES; MALE; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; TRANSDUCTION, GENETIC;

EID: 34547569057     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00626.x     Document Type: Article

References (34)

1. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988 55 : 1179 88.
2. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988 55 : 1189 93.
3. Noguchi H, Matsumoto S. Protein transduction technology offers a novel therapeutic approach for diabetes. J Hepatobiliary Pancreat Surg 2006 13 : 306 13.
4. Snyder EL, Dowdy SF. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin Drug Deliv 2005 2 : 43 51.
5. Harbour JW, Worley L, Ma D, Cohen M. Transducible peptide therapy for uveal melanoma and retinoblastoma. Arch Ophthalmol 2002 120 : 1341 6.
6. Arnt CR, Chiorean MV, Heldebrant MP, Gores GJ, Kaufmann SH. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 2002 277 : 44236 43.
7. Vucic D, Deshayes K, Ackerly H, Pisabarro MT, Kadkhodayan S, Fairbrother WJ, et al. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem 2002 277 : 12275 9.
8. Mai JC, Mi Z, Kim SH, Ng B, Robbins PD. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 2001 61 : 7709 12.
9. Hosotani R, Miyamoto Y, Fujimoto K, Doi R, Otaka A, Fujii N, et al. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice. Clin Cancer Res 2002 8 : 1271 6.
10. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 2002 298 : 846 50.
11. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain Injury and neuronal apoptosis. J Neurosci 2002 22 : 5423 31.
12. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 2000 6 : 1362 7.
13. Schranz DB, Lernmark A. Immunology in diabetes: an update. Diabetes Metab Rev 1998 14 : 3 29.
14. Adorini L, Gregori S, Harrison LC. Understanding autoimmune diabetes: insights from mouse models. Trends Mol Med 2002 8 : 31 8.
15. Notkins AL. Immunologic and genetic factors in type 1 diabetes. J Biol Chem 2002 277 : 43545 8.
16. Jun HS, Yoon JW. Approaches for the cure of type 1 diabetes by cellular and gene therapy. Curr Gene Ther 2005 5 : 249 62.
17. Weir GC, Bonner-Weir S. Scientific and political impediments to successful islet transplantation. Diabetes 1997 46 : 1247 56.
18. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev 2003 120 : 65 80.
19. Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1(1-37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 2003 100 : 5034 9.
20. Koizumi M, Nagai K, Kida A, Kami K, Ito D, Fujimoto K, et al. Forced expression of PDX-1 induces insulin production in intestinal epithelia. Surgery 2006 140 : 273 80.
21. Yoshida S, Kajimoto Y, Yasuda T, Watada H, Fujitani Y, Kosaka H, et al. PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes 2002 51 : 2505 13.
22. Kojima H, Nakamura T, Fujita Y, Kishi A, Fujimiya M, Yamada S, et al. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 2002 51 : 1398 408.
23. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997 11 : 2323 34.
24. Kaneto H, Nakatani Y, Miyatsuka T, Matsuoka TA, Matsuhisa M, Hori M, et al. PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance. Diabetes 2005 54 : 1009 22.
25. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003 9 : 596 603.
26. Chen J, Li G, Lu J, Chen L, Huang Y, Wu H, et al. A novel type of PTD, common helix-loop-helix motif, could efficiently mediate protein transduction into mammalian cells. Biochem Biophys Res Commun 2006 347 : 931 40.
27. Noguchi H, Bonner-Weir S, Wei FY, Matsushita M, Matsumoto S. BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes 2005 54 : 2859 66.
28. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000 6 : 568 72.
29. Ber I, Shternhall K, Perl S, Ohanuna Z, Goldberg I, Barshack I, et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem 2003 278 : 31950 7.
30. Wang AY, Ehrhardt A, Xu H, Kay MA. Adenovirus transduction is required for the correction of diabetes using Pdx-1 or neurogenin-3 in the liver. Mol Ther 2007 15 : 255 63.
31. Potten CS, Booth C, Pritchard DM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997 78 : 219 43.
32. Miyachi T, Maruyama H, Kitamura T, Nakamura S, Kawakami H. Structure and regulation of the human NeuroD (BETA2/BHF1) gene. Brain Res Mol Brain Res 1999 69 : 223 31.
33. Noguchi H, Matsumoto S. Protein transduction technology: a novel therapeutic perspective. Acta Med Okayama 2006 60 : 1 11.
34. Kaur P, Potten CS. Circadian variation in migration velocity in small intestinal epithelium. Cell Tissue Kinet 1986 19 : 591 9.